Budget Impact of a Fixed-Dose Combination Therapy of Lesinurad and Allopurinol for Second-Line Gout Therapy- A US Commercial Health Plan Perspective
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1316
https://www.valueinhealthjournal.com/article/S1098-3015(18)31619-X/fulltext
Title :
Budget Impact of a Fixed-Dose Combination Therapy of Lesinurad and Allopurinol for Second-Line Gout Therapy- A US Commercial Health Plan Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31619-X&doi=10.1016/j.jval.2018.04.1316
First page :
Section Title :
Open access? :
No
Section Order :
567